CAS 480-18-2 Dihydroquercetin Plant Extract Dihydroquercetin Taxifolin Powder Taxifolin Dihydroquercetin
Product Description
Product Details
Product Name |
Dihydroquercetin |
Appearance |
White Powder |
CAD No. |
480-18-2 |
MF |
C15H12O7 |
Dihydroquercetin is not mutagenic and less toxic than the related compound quercetin. It acts as a potentialchemopreventive agent by regulating genes via an ARE-dependent mechanism. Taxifolin has shown to inhibit theovarian cancer cell growth in a dose-dependent manner. There is also a strong correlation (with a correlation coefficient of 0.93) between the antiproliferative effects of dihydroquercetin (DHQ, Dihydroquercetin) derivatives on murine skin fibroblasts and human breast cancer cells.
Application&Function
1. Inhibit the synthesis of fat and cholesterol
Dihydroquercetin can affect lipid metabolism by regulating the activity of enzyme, which can reduce the synthesis of liver fat, inhibit the synthesis of cholesterol in cells, and inhibit the synthesis of cholesterol esterification, triesters glycerol and phospholipids in cells.
2. Effects on lymphocytes
Dihydroquercetin can inhibit the proliferation of normal lymphocytes to different degrees, but has no effect on non-malignant cells.Can be used to treat malignant lymphocytic disease.
3. Anticancer effect
Dihydroquercetin can mildly inhibit the growth of phosphocell carcinoma (HTB43) (8mg/mL).The growth of HTB43 cells was inhibited gently in a concentration of 2 ~ 8mg/mL.
Specification